| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Vir Biotechnology, Inc. | Director | Common Stock | 15.8K | $24.2K | $1.53 | May 22, 2023 | Direct |
| Vir Biotechnology, Inc. | Director | Stock Option (Right to Buy) | 12.1K | $18.4K | $1.53 | May 22, 2023 | Direct |
| Rapport Therapeutics, Inc. | Director | Stock Option (Right to Buy) | 29.8K | Nov 7, 2024 | Direct | ||
| Third Harmonic Bio, Inc. | Director | Employee Stock Option (right to buy) | 13.7K | Mar 6, 2023 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| RAPP | Rapport Therapeutics, Inc. | Nov 7, 2024 | 1 | $0 | 4 | Nov 7, 2024 | Director |
| RAPP | Rapport Therapeutics, Inc. | Nov 7, 2024 | 0 | $0 | 3 | Nov 7, 2024 | Director |
| IMCR | Immunocore Holdings plc | Jan 2, 2024 | 0 | $0 | 3 | Jan 2, 2024 | Director |
| VIR | Vir Biotechnology, Inc. | May 22, 2023 | 2 | $0 | 4 | May 24, 2023 | Director |
| THRD | Third Harmonic Bio, Inc. | Mar 6, 2023 | 2 | $0 | 4 | Mar 8, 2023 | Director |
| THRD | Third Harmonic Bio, Inc. | Oct 26, 2022 | 1 | $0 | 4 | Oct 27, 2022 | Director |
| THRD | Third Harmonic Bio, Inc. | Sep 14, 2022 | 0 | $0 | 3 | Sep 14, 2022 | Director |
| VIR | Vir Biotechnology, Inc. | May 23, 2022 | 2 | $0 | 4 | May 25, 2022 | Director |
| VIR | Vir Biotechnology, Inc. | May 21, 2021 | 2 | $0 | 4 | May 25, 2021 | Director |